Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Gastric cancer patients less than 50 years of age exhibit significant downregulation of E-cadherin and CDX2 compared to older reference populations.

Schildberg CW, Abba M, Merkel S, Agaimy A, Dimmler A, Schlabrakowski A, Croner R, Leupold JH, Hohenberger W, Allgayer H.

Adv Med Sci. 2014 Mar;59(1):142-6. doi: 10.1016/j.advms.2014.03.002.

PMID:
24797991
2.

A clinicopathological study on the expression of cadherin-17 and caudal-related homeobox transcription factor (CDX2) in human gastric carcinoma.

Ge J, Chen Z, Wu S, Yuan W, Hu B, Chen Z.

Clin Oncol (R Coll Radiol). 2008 May;20(4):275-83. doi: 10.1016/j.clon.2008.01.013.

PMID:
18353622
3.

CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach.

Ko S, Chu KM, Luk JM, Wong BW, Yuen ST, Leung SY, Wong J.

J Pathol. 2005 Apr;205(5):615-22.

PMID:
15732140
4.

Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer.

Huang LP, Yu YH, Sheng C, Wang SH.

Int J Gynecol Cancer. 2012 Sep;22(7):1170-6. doi: 10.1097/IGC.0b013e318261d89c.

PMID:
22810971
5.

CDX2 as a prognostic marker in gastric cancer.

Masood MA, Loya A, Yusuf MA.

Acta Gastroenterol Belg. 2016 Apr-Jun;79(2):197-200.

PMID:
27382937
6.

Immunohistochemical molecular phenotypes of gastric cancer based on SOX2 and CDX2 predict patient outcome.

Camilo V, Barros R, Celestino R, Castro P, Vieira J, Teixeira MR, Carneiro F, Pinto-de-Sousa J, David L, Almeida R.

BMC Cancer. 2014 Oct 9;14:753. doi: 10.1186/1471-2407-14-753.

7.

Homeoprotein Cdx2 and nuclear PTEN expression profiles are related to gastric cancer prognosis.

Bai Z, Ye Y, Chen D, Shen D, Xu F, Cui Z, Wang S.

APMIS. 2007 Dec;115(12):1383-90. doi: 10.1111/j.1600-0463.2007.00654.x.

PMID:
18184409
8.
9.

Expression of osteopontin and CDX2: indications of phenotypes and prognosis in advanced gastric cancer.

Zhang X, Tsukamoto T, Mizoshita T, Ban H, Suzuki H, Toyoda T, Tatematsu M.

Oncol Rep. 2009 Mar;21(3):609-13.

PMID:
19212618
10.

Expression of Cdx2 and the phenotype of advanced gastric cancers: relationship with prognosis.

Mizoshita T, Tsukamoto T, Nakanishi H, Inada K, Ogasawara N, Joh T, Itoh M, Yamamura Y, Tatematsu M.

J Cancer Res Clin Oncol. 2003 Dec;129(12):727-34.

PMID:
14557879
11.

[Expressions of homeobox transcription factor-2 and E-cadherin in gastric carcinoma and their clinical significance].

Ge J, Chen ZH, Chen ZK, Yuan WJ.

Nan Fang Yi Ke Da Xue Xue Bao. 2008 Feb;28(2):279-1281. Chinese.

12.

[Clinicopathologic and immunohistochemical study on early gastric signet-ring cell carcinoma].

Xiong ZF, Xiao H, Tan YS.

Zhonghua Bing Li Xue Za Zhi. 2010 Jul;39(7):442-6. Chinese.

PMID:
21055171
13.

Expression and significance of homeodomain protein Cdx2 in gastric carcinoma and precancerous lesions.

Qin R, Wang NN, Chu J, Wang X.

World J Gastroenterol. 2012 Jul 7;18(25):3296-302. doi: 10.3748/wjg.v18.i25.3296.

14.

Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.

Silva EM, Begnami MD, Fregnani JH, Pelosof AG, Zitron C, Montagnini AL, Soares FA.

Gastric Cancer. 2008;11(3):149-59. doi: 10.1007/s10120-008-0468-5.

PMID:
18825309
15.

Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures.

Wang XT, Wei WY, Kong FB, Lian C, Luo W, Xiao Q, Xie YB.

J Exp Clin Cancer Res. 2012 Nov 26;31:98. doi: 10.1186/1756-9966-31-98.

16.

Positive association of up-regulated Cripto-1 and down-regulated E-cadherin with tumour progression and poor prognosis in gastric cancer.

Zhong XY, Zhang LH, Jia SQ, Shi T, Niu ZJ, Du H, Zhang GG, Hu Y, Lu AP, Li JY, Ji JF.

Histopathology. 2008 Apr;52(5):560-8. doi: 10.1111/j.1365-2559.2008.02971.x.

PMID:
18312357
17.

Clinicopathological significant and prognostic influence of cadherin-17 expression in gastric cancer.

Ito R, Oue N, Yoshida K, Kunimitsu K, Nakayama H, Nakachi K, Yasui W.

Virchows Arch. 2005 Oct;447(4):717-22.

PMID:
16044349
18.

CDX2 expression is increased in gastric cancers with less invasiveness and intestinal mucin phenotype.

Ha Kim G, Am Song G, Youn Park D, Han Lee S, Hyun Lee D, Oh Kim T, Jae Jo H, Heo J, Hwan Kang D, Cho M.

Scand J Gastroenterol. 2006 Aug;41(8):880-6.

PMID:
16803685
19.

Aberrant expression of the autocrine motility factor receptor correlates with poor prognosis and promotes metastasis in gastric carcinoma.

Huang Z, Zhang N, Zha L, Mao HC, Chen X, Xiang JF, Zhang H, Wang ZW.

Asian Pac J Cancer Prev. 2014;15(2):989-97.

20.

The contribution of cell phenotype to the behavior of gastric cancer.

Solcia E, Klersy C, Vanoli A, Grillo F, Manca R, Tava F, Luinetti O, Fiocca R.

Gastric Cancer. 2013 Oct;16(4):462-71. doi: 10.1007/s10120-012-0208-8. Erratum in: Gastric Cancer. 2013 Oct;16(4):472.

PMID:
23329390
Items per page

Supplemental Content

Support Center